Low Dose Daily Corticosteroid Tapering Regimen Allows Highly Effective and Practical Desensitization for Multiple Myeloma Patients with Skin Rash after Immunomodulatory Drugs

被引：1
|
作者：
Firoozmand, Amin
Ali, Naveed
Ahmed, Nausheen
Fu, Pingfu
Cao, Shufen
Brown, George
Schmikla, Hannah
Driscoll, James J.
O'Brien, Timothy
Caimi, Paolo
de Lima, Marcos
Malek, Ehsan
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-140800
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 13 条
  • [1] A highly effective and practical desensitization regimen: Results in comparable clinical outcomes for multiple myeloma patients with skin rash after immunomodulatory drugs.
    Firoozmand, Amin
    Ali, Naveed
    Ahmed, Nausheen
    Fu, Pingfu
    Cao, Shufen
    Brown, George
    Schmikla, Hannah
    Driscoll, James Joseph
    O'Brien, Timothy
    Caimi, Paolo Fabrizio
    De Lima, Marcos J. G.
    Malek, Ehsan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Skin rash after immunomodulatory drugs for plasma cell neoplasms: effective practical corticosteroid desensitisation regimen
    Ali, Naveed
    Schmikla, Hannah
    Chopra, Rishil
    Brown, George
    Fu, Pingfu
    Cao, Shufen
    Driscoll, James
    Ravi, Gayathri
    Van Heeckeren, Willem
    Malek, Ehsan
    BMJ SUPPORTIVE & PALLIATIVE CARE, 2024, 14 (E2) : e2199 - e2201
  • [3] A Highly Effective and Practical Corticosteroid Regimen to Overcome Skin Rash Associated with Immunomodulatory Drugs Allowing Reinstitution of Therapy
    Ali, Naveed
    Schmikla, Hannah
    Brown, George
    Cooper, Brenda
    Metheny, Leland
    Caimi, Paolo
    Patel, Seema
    Driscoll, James J.
    de Lima, Marcos
    Malek, Ehsan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S390 - S391
  • [4] Busulfan and cyclophosphamide as a conditioning regimen for autologous transplantation in patients with multiple myeloma after treatment with proteasome inhibitors and/or immunomodulatory drugs
    Kang, Ka-Won
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Choi, Chul Won
    Lee, Byung-Hyun
    Lee, Se Ryeon
    Sung, Hwa Jung
    Park, Yong
    Kim, Byung Soo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S41 - S41
  • [5] Understanding the Dose Regimen for Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma (MM) after Prior Proteasome Inhibitors (PIs) and Immunomodulatory Drugs (IMiDs): A Quantitative Pharmacologic Perspective
    Xu, Xu Steven
    Yan, Xiaoyu
    Puchalski, Thomas
    Lonial, Sagar
    Lokhorst, Henk M.
    Voorhees, Peter M.
    Liu, Kevin
    Khan, Imran
    Jansson, Richard
    Ahmadi, Tahamtan
    Ruixo, Juan Jose Perez
    Zhou, Honghui
    Clemens, Pamela L.
    BLOOD, 2015, 126 (23)
  • [6] Low dose velcade, thalidomide and dexamethasone (LD-VTD): An effective regimen for relapsed and refractory multiple myeloma patients
    Ciolli, S
    Leoni, F
    Gigli, F
    Rigacci, L
    Bosi, A
    LEUKEMIA & LYMPHOMA, 2006, 47 (01) : 171 - 173
  • [7] Low-dose preparative regimen and allogeneic stem cell transplantation in patients with multiple myeloma relapsing after autografting.
    Einsele, H
    Bamberg, M
    Schäfer, HJ
    Hebart, H
    Bader, P
    Budach, W
    Faul, C
    Brugger, W
    Kanz, L
    BLOOD, 1999, 94 (10) : 309B - 309B
  • [8] Toxicity and early response after single daily dose of intravenous busulfan and melphalan as conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    de la Rubia, J.
    Lahuerta, J. J.
    Gonzalez, J. D.
    Ribas, P.
    Solano, C.
    Sanz, M. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 192 - 192
  • [9] Toxicity and early response after single daily dose of intravenous busulfan and melphalan as conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Blanes, Margarita
    De la Rubia, Javier
    Lahuerta, Juan J.
    Gonzalez, Juan D.
    Ribas, Paz
    Solano, Carlos
    Sanz, Miguel A.
    BLOOD, 2007, 110 (11) : 307B - 307B
  • [10] Low-dose thalidomide in combination with oral weekly cyclophosphamide and pulsed dexamethasone is a well tolerated and effective regimen in patients with relapsed and refractory multiple myeloma
    Kyriakou, C
    Thomson, K
    D'Sa, S
    Flory, A
    Hanslip, J
    Goldstone, AH
    Yong, KL
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (06) : 763 - 770
12